rs387906329
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM4PP3PP5
The NM_020661.4(AICDA):c.177_185del(p.Leu59_Leu62delinsPhe) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. Variant has been reported in ClinVar as Pathogenic (no stars). Synonymous variant affecting the same amino acid position (i.e. L59L) has been classified as Likely benign.
Frequency
Genomes: not found (cov: 32)
Consequence
AICDA
NM_020661.4 inframe_deletion
NM_020661.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 8.88
Genes affected
AICDA (HGNC:13203): (activation induced cytidine deaminase) This gene encodes a RNA-editing deaminase that is a member of the cytidine deaminase family. AICDA is specifically expressed and active in germinal center-like B cells. In the germinal center, AICDA is involved in somatic hypermutation, gene conversion, and class-switch recombination of immunoglobulin genes. An epigenetic role in neoplastic transformation and lymphoma progression has been experimentally ascribed to AICDA using mouse models. Defects in this gene are the cause of autosomal recessive hyper-IgM immunodeficiency syndrome type 2 (HIGM2). [provided by RefSeq, Jul 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM1
?
In a chain Single-stranded DNA cytosine deaminase (size 197) in uniprot entity AICDA_HUMAN there are 23 pathogenic changes around while only 3 benign (88%) in NM_020661.4
PM4
?
Nonframeshift variant in NON repetitive region in NM_020661.4.
PP3
?
No computational evidence supports a deleterious effect, but strongly conserved according to phyloP
PP5
?
Variant 12-8605456-GAGGAAGAGC-G is Pathogenic according to our data. Variant chr12-8605456-GAGGAAGAGC-G is described in ClinVar as [Pathogenic]. Clinvar id is 5130.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AICDA | NM_020661.4 | c.177_185del | p.Leu59_Leu62delinsPhe | inframe_deletion | 3/5 | ENST00000229335.11 | |
AICDA | NM_001330343.2 | c.177_185del | p.Leu59_Leu62delinsPhe | inframe_deletion | 3/5 | ||
AICDA | NM_001410970.1 | c.177_185del | p.Leu59_Leu62delinsPhe | inframe_deletion | 3/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AICDA | ENST00000229335.11 | c.177_185del | p.Leu59_Leu62delinsPhe | inframe_deletion | 3/5 | 1 | NM_020661.4 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD3 genomes
?
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome ? Cov.: 32
GnomAD4 genome
?
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Hyper-IgM syndrome type 2 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 01, 2000 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at